Downregulation of Rnd3/Rhoe in Glioblastoma Patients Promotes Tumorigenesis Through Augmentation of Notch Transcriptional Complex Activity
Baohui Liu,Xi Lin,Xiangsheng Yang,Huimin Dong,Xiaojing Yue,Kelsey C. Andrade,Zhentao Guo,Jian Yang,Liquan Wu,Xiaonan Zhu,Shenqi Zhang,Daofeng Tian,Junmin Wang,Qiang Cai,Qizuan Chen,Shanping Mao,Qianxue Chen,Jiang Chang
DOI: https://doi.org/10.1002/cam4.484
IF: 4.711
2015-01-01
Cancer Medicine
Abstract:Activation of Notch signaling contributes to glioblastoma multiform (GBM) tumorigenesis. However, the molecular mechanism that promotes the Notch signaling augmentation during GBM genesis remains largely unknown. Identification of new factors that regulate Notch signaling is critical for tumor treatment. The expression levels of RND3 and its clinical implication were analyzed in GBM patients. Identification of RND3 as a novel factor in GBM genesis was demonstrated in vitro by cell experiments and in vivo by a GBM xenograft model. We found that RND3 expression was significantly decreased in human glioblastoma. The levels of RND3 expression were inversely correlated with Notch activity, tumor size, and tumor cell proliferation, and positively correlated with patient survival time. We demonstrated that RND3 functioned as an endogenous repressor of the Notch transcriptional complex. RND3 physically interacted with NICD, CSL, and MAML1, the Notch transcriptional complex factors, promoted NICD ubiquitination, and facilitated the degradation of these cofactor proteins. We further revealed that RND3 facilitated the binding of NICD to FBW7, a ubiquitin ligase, and consequently enhanced NICD protein degradation. Therefore, Notch transcriptional activity was inhibited. Forced expression of RND3 repressed Notch signaling, which led to the inhibition of glioblastoma cell proliferation in vitro and tumor growth in the xenograft mice in vivo. Downregulation of RND3, however, enhanced Notch signaling activity, and subsequently promoted glioma cell proliferation. Inhibition of Notch activity abolished RND3 deficiency-mediated GBM cell proliferation. We conclude that downregulation of RND3 is responsible for the enhancement of Notch activity that promotes glioblastoma genesis.